Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis.

Genes and immunity - 1 Sept 2005

Camp N J, Cox A, di Giovine F S, McCabe D, Rich W, Duff G W

Abstract excerpt

Biological activity of the IL-1 system depends on the balance between two proinflammatory proteins (IL-1alpha and IL-1beta) and the related anti-inflammatory protein, the IL-1 receptor antagonist (IL-1Ra). The genes for these proteins lie within 430 kb on human chromosome 2. Based on a clinical trial of human recombinant IL-1ra in rheumatoid arthritis, we tested whether IL-1 genotype might be related to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Arthritis, Rheumatoid
Share to Double-Blind Method

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Drug Resistance

Share to Interleukin-1

Share to Interleukin 1 Receptor Antagonist Protein

Share to Recombinant Proteins

Share to Sialoglycoproteins

Source

Identifiers

PMID: 15931231
DOI: 10.1038/sj.gene.6364228

Genes

IL1A
IL1B

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Evidence of a pharmacogenomic response to interleukin-l receptor antagonist in rheumatoid arthritis.PMID 15931231Read ↗

Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis.Semantic proximity Read ↗

IL-1B and IL-1Ra gene polymorphisms and disease severity in rheumatoid arthritis: interaction with their plasma levelsSemantic proximity Read ↗

Associations between interleukin-1 and IL-1 receptor antagonist polymorphisms and susceptibility to rheumatoid arthritis: A meta-analysis.Semantic proximity Read ↗

Genetic variation of the interleukin-1 family and nongenetic factors determining the interleukin-1 receptor antagonist phenotypes.Semantic proximity Read ↗

Interleukin-1 receptor antagonist gene polymorphism in patients with rheumatoid arthritis in India.Semantic proximity Read ↗

Interleukin-1 polymorphisms are associated with the inflammatory response in human muscle to acute resistance exercise.Semantic proximity Read ↗

Pharmacogenomics of tumor necrosis factor antagonists in rheumatoid arthritis.Semantic proximity Read ↗

Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis.Semantic proximity Read ↗

Common genetic variation in the gene encoding interleukin-1-receptor antagonist (IL-1RA) is associated with altered circulating IL-1RA levels.Semantic proximity Read ↗

Genetic control of IL-1beta bioactivity through differential regulation of the IL-1 receptor antagonist.Semantic proximity Read ↗

Interleukin 1 gene polymorphism and susceptibility to disease.Semantic proximity Read ↗

Influence of interleukin-1 receptor antagonist gene polymorphism on disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.